Nathan Charles, a former Australia rugby union international who famously battled cystic fibrosis to achieve a career in a high‑impact sport, has publicly disclosed that he has been diagnosed with motor neurone disease (MND). The 37‑year‑old, who earned his first Test cap in 2014 and accumulated four appearances for the Wallabies—including a memorable 12‑12 draw against the All Blacks—announced that he now shares the same diagnosis recently given to former NRL star Jai Arrow. MND is a collective term for a range of progressive neurological disorders in which the motor neurons that control voluntary muscle movement gradually deteriorate. The most prevalent form is amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s disease.
These conditions lead to muscle weakness, loss of coordination, and ultimately, severe impairment of respiratory and limb function. While research continues worldwide, there is currently no cure, and treatment focuses on managing symptoms and preserving quality of life. During a candid interview on Stan Sport with former Wallabies lock‑turned‑commentator Justin Harrison, Charles opened up about his recent diagnosis. He explained that for an extended period he was uncertain about the cause of his declining health.
"I underwent countless tests and consulted a long list of specialists, but nothing gave us a clear answer. My condition kept getting worse," he said.
"Only in the past few weeks did doctors finally confirm that I have motor neurone disease. It’s been an overwhelming and extremely challenging revelation. I know there is no cure, and the disease will gradually erode my physical abilities, potentially shortening my life." Charles’ rugby résumé spans several elite teams. He played Super Rugby with the Perth‑based Western Force and later the Melbourne Rebels, before moving to England where he turned out for Gloucester, Bath and Wasps.
After hanging up his boots in 2018, he transitioned into administration, serving as chief executive of Rugby Western Australia and taking an active role with the Sydney University Rugby Club, where he contributes to player development and community outreach. The news of Charles’ diagnosis joins a growing list of high‑profile rugby figures who have been affected by MND. Former England captain and 2003 World Cup winner Lewis Moody was diagnosed last year, while the sport has also mourned the loss of former Great Britain rugby league legend Rob Burrow and Scottish union icon Doddie Weir, both of whom succumbed to the disease.
Their stories have helped raise public awareness and funding for MND research. In a personal blog post, Charles reflected on his lifelong battle with cystic fibrosis, a genetic disorder that primarily impairs the lungs and digestive system.
He was diagnosed at just three months old and was once told he might not survive beyond his tenth birthday. Defying those grim predictions, he not only reached professional sport but also became a vocal advocate for those living with chronic illness. "I constantly push boundaries and serve as living proof that anything is possible," he wrote.
"My personal mission is to exceed the average life expectancy of 37 years for people with cystic fibrosis." Now, faced with a second, unrelated, life‑threatening condition, Charles expressed a mixture of irony and determination. "I was born with a serious illness and fought it with everything I had. Now another disease appears, and it feels almost cruel that something else will try to take me down," he said. "But I will continue to fight, raise awareness, and support research, just as I have done with cystic fibrosis." The Australian national team, preparing for the upcoming Bledisloe Cup series against New Zealand, quickly rallied around their teammate.
The Wallabies posted a supportive message on their social media platforms, and captain Harry Wilson offered a heartfelt statement: "We know you have a tough road ahead, but we’re with you every step of the way." Charles’ situation underscores the broader challenges athletes face when confronting serious health issues after retirement. While the physical demands of professional rugby are intense, the transition to post‑sport life can bring hidden vulnerabilities, especially for those with pre‑existing conditions.
His openness about MND not only humanises the often‑glorified image of elite athletes but also shines a spotlight on the need for continued medical research, early diagnosis, and comprehensive care for neurodegenerative diseases. In addition to his public statements, Charles has pledged to use his platform to support MND charities and to participate in fundraising events.
He hopes that sharing his journey will inspire others to seek medical advice early, support research initiatives, and foster a community of empathy for those living with motor neurone disease. As the rugby world watches, Charles remains a symbol of resilience—first battling cystic fibrosis to reach the pinnacle of his sport, and now confronting a new, formidable opponent with the same courage and determination that defined his playing career.